Cardiovascular DiseasesHeptanoic AcidsStrokeMyocardial InfarctionRisk FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsFollow-Up StudiesPyrrolesMargarineAnticholesteremic AgentsProportional Hazards ModelsTreatment OutcomeAcute Coronary SyndromeProspective StudiesRandomized Controlled Trials as TopicKaplan-Meier EstimateBiological MarkersPredictive Value of TestsCoronary Artery DiseasePlatelet Aggregation InhibitorsDouble-Blind MethodRisk AssessmentCholesterol, LDLAntihypertensive AgentsHypertensionPrognosisAspirinC-Reactive ProteinIncidenceDiabetes Mellitus, Type 2Coronary DiseaseRiskDrug Therapy, CombinationHeart FailureCohort StudiesBlood PressureTime FactorsAtherosclerosisPravastatinDiabetic AngiopathiesKidney Failure, ChronicRenal Insufficiency, ChronicRenal DialysisJapanTiclopidinePeripheral Vascular DiseasesPlaque, AtheroscleroticCalcinosisFluorobenzenesAngina PectorisMultivariate AnalysisBrachial ArteryPrimary PreventionCoronary AngiographyDiabetes ComplicationsSecondary PreventionHypolipidemic AgentsKidney DiseasesNatriuretic Peptide, BrainDeath, Sudden, CardiacSeverity of Illness IndexCarotid Artery DiseasesComorbidityChlorthalidoneCarotid ArteriesAngioplasty, Balloon, CoronaryDyslipidemiasChi-Square DistributionAngiotensin-Converting Enzyme InhibitorsRetrospective StudiesBlood Pressure Monitoring, AmbulatoryCardiovascular AgentsRecurrenceDisease ProgressionCholesterol, HDLAnkle Brachial IndexFosinoprilTunica MediaCarotid Intima-Media ThicknessGlomerular Filtration RateDeathSurvival RateAlbuminuriaCause of DeathPeripheral Arterial DiseaseThrombosisMetabolic Syndrome XSurvival AnalysisEndpoint DeterminationHypertrophy, Left VentricularHypercholesterolemiaOdds RatioHospitalizationAnkleAge FactorsCystatin CAmlodipineAngina, UnstableMyocardial IschemiaDiabetes Mellitus